GeneralConnection.com ➔ Dictionary
Dictionary Search

narcoleptic

Synonyms

Adjective

1. hypersomnia

Noun

1. sick person

2. diseased person, sufferer, soporific

3. hypnotic

Usage
Narcolepsy is (not) an autoimmune disease - Nature
Once-Nightly Oxybate in Narcolepsy: Real-World Outcomes Primary Care Should Know - Patient Care Online
Narcolepsy doesn't just appear, but sleepy kids may get diagnosed with something else - WKYC
Novel Narcolepsy Drug Delivers Benefits Beyond Wakefulness - Medscape
Severe narcolepsy found to damage a second brain region - UCLA Health
Orexin Agonist Shows Promise for Treating Narcolepsy, Hypersomnia: Richard Bogan, MD - AJMC
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM - NeurologyLive
A teen slept through her childhood. The answer took years to find - 9News
Katie Morton Discusses Managing Narcolepsy Symptoms During Pregnancy — More Here - Bachelor Nation
Individualizing Narcolepsy Care: Real-World Oxybate Outcomes - Psychiatric Times
Novel Patient-Reported Outcome Instrument Developed to Measure Functional Impacts of Narcolepsy - Docwire News
FDA approves Wakix for cataplexy in pediatric narcolepsy - American Academy of Sleep Medicine | AASM
Human narcolepsy is linked to degeneration of both locus coeruleus and hypocretin neurons - Nature
Patients With Narcolepsy Experience Significant Burden of Disease - AJMC
Alixorexton for the Treatment of Narcolepsy Type 2: Insights From SLEEP 2026 - Psychiatric Times
Oveporexton Improves REM Sleep Architecture and Sleep-Related Symptoms in Phase 3 Narcolepsy Type 1 Studies - NeurologyLive
MRI Study Reveals Hypothalamic Atrophy Across Multiple Subregions in Narcolepsy Type 1 - AJMC
NeuroVoices: Jerome Siegel, PhD, on Locus Coeruleus Neuron Loss as a Key Pathologic Feature of Narcolepsy - NeurologyLive
Oveporexton Shows Gains in Cognition, Sleep Quality in Narcolepsy: Elena Koundourakis, PhD - AJMC
Real-World Outcomes With Sodium Oxybate in Narcolepsy - Psychiatric Times
New Data on Alixorexton for Narcolepsy Type 2: Insights From Richard K. Bogan, MD - Psychiatric Times
Why Narcolepsy Is Often Missed—and How to Spot It - Psychiatry Online
Why do 'sleep attacks' happen? Study points to an autoimmune trigger in narcolepsy - Medical Xpress
A conversation exploring the newest discovery in narcolepsy research, with sleep researcher Jerome Siegel, Ph.D. - Managed Healthcare Executive
Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications for precision sleep medicine - Frontiers
Oveporexton Improves Daily Function, Cognition, and Nighttime Sleep in Narcolepsy Type 1 - Psychiatric Times
Residual Cataplexy Common in Treated Narcolepsy Type 1, CRESCENDO Survey Finds - Patient Care Online
ASPIRE Survey Study Results: New Insights on Patients With Narcolepsy & Idiopathic Hypersomnia - Psychiatric Times
Eli Lilly Completes Acquisition of Centessa Pharmaceuticals to Advance Narcolepsy Treatments - Sleep Review
First orexin agonists address root cause of narcolepsy - Nature
Oveporexton Improves Cognition in Narcolepsy Type 1 - Psychiatric Times
Oveporexton Effective in Improving REM Sleep, Improving Cognitive Function in Narcolepsy - AJMC
FDA grants breakthrough designation for narcolepsy drug alixorexton - American Academy of Sleep Medicine | AASM
Narcolepsy Comorbidities, Quality of Life, and Risk Factors - NeurologyLive
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion - The New York Times
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia - PR Newswire
DUET Trial: Low-Sodium Oxybate Significantly Consolidates Nighttime Sleep Architecture in Narcolepsy - AJMC
Surprisingly, Narcolepsy Type 1 Linked to Neurodegeneration Beyond That of Orexin Neurons - Sleep Review
Identifying Narcolepsy in Psychiatric Populations - Psychiatric Times
Narcolepsy Type 2 in an Adolescent With Childhood Obstructive Sleep Apnea and Coexisting Absence Epilepsy: A Case Report - Cureus
Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal - STAT
Takeda (TSE:4502) Unveils Phase 3 Wins In Narcolepsy And Psoriasis - Yahoo Finance
FDA Grants Orexin Agonist Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1 - NeurologyLive
Narcolepsy Treatment Considerations in Pediatric Patients - Psychiatric Times
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline - TradingView
Narcolepsy Drug Shows Promise for Boosting Cognition - Psychiatrist.com
EISAI TO BEGIN ENROLLING PHASE 2 STUDY IN PATIENTS WITH NARCOLEPSY - PR Newswire
Takeda’s new study data for oveporexton shows improvements in narcolepsy type 1 - PMLiVE
'Conclusive Evidence That Narcolepsy Type 1 Is a Result of the Body’s Own Immune System' - Sleep Review
Diagnosing narcolepsy: What to know about polysomnograms and multiple sleep latency tests - Mayo Clinic Press
Understanding Narcolepsy as More Than a Sleep Disorder - NeurologyLive
Narcolepsy Treatment Considerations in Pediatric Patients - NeurologyLive
FDA Expands Indication for Pitolisant to Treat Cataplexy in Pediatric Narcolepsy - NeurologyLive
Your guide to narcolepsy treatments and side effects, according to a sleep medicine expert - Mayo Clinic Press
New AAN Poster Presentation on Alixorexton for Narcolepsy Type 1: Improvement in Disease Severity, Cognitive Functioning, and Fatigue - Psychiatric Times
Reboxetine Reduces Overall Narcolepsy Symptom Severity and Improves EDS, Mood-Related Symptoms - Pharmacy Times – Pharmacy Practice News and Expert Insights
Phase 3 Brilliance Studies Initiated on Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 - Psychiatric Times
8 Ways to Recharge When You’re Living With Narcolepsy - Everyday Health
Axsome fends off generic competition to narcolepsy med Sunosi until 2040 - Fierce Pharma
Multidisciplinary Approaches to Long-Term Narcolepsy Care - Psychiatric Times
Assessing DEA Scheduling and Emerging Therapies in Narcolepsy - Psychiatric Times
Evaluating Pitolisant and Other Pharmacologic Treatment Options for Narcolepsy - Psychiatric Times
After years of exhaustion, a South Philadelphia artist raises awareness for narcolepsy - CBS News
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1 - Business Wire
MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and More - Psychiatry Online
Orexin Deficiency in Narcolepsy: Molecular Mechanisms, Clinical Phenotypes, and Emerging Therapeutic Frontiers - Wiley Online Library
Reviewing the Prevalence and Underdiagnosis of Narcolepsy - Psychiatric Times
Narcolepsy can impact your child’s memory — Here are the best tips to help keep on track - Mayo Clinic Press
Alkermes plans label expansion for Avadel-acquired narcolepsy drug - FirstWord Pharma
Bupropion for Treatment of Depression and Narcolepsy in a Postpartum Patient - Psychiatrist.com
Lilly to buy narcolepsy drug developer for $6.3 billion - Chemical & Engineering News
Alkermes to Present Sustained Efficacy Data for Alixorexton in Narcolepsy Type 1 - Sleep Review
How Alixorexton could transform narcolepsy treatment - American Society for Biochemistry and Molecular Biology
Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia - PR Newswire
Video: How to Diagnose Narcolepsy and Avoid Common Pitfalls – With Expert Insights - Psychiatry Advisor
FDA Accepts New Drug Application for Orexin Agonist Oveporexton in Narcolepsy Type 1, Grants Priority Review - NeurologyLive
What to know about narcolepsy - Managed Healthcare Executive
Attention and inhibition deficits in narcolepsy type 1: behavioral and electrophysiological markers - Nature
Axsome pushes back generic entry for narcolepsy drug until 2040 - Endpoints News
FDA Grants Breakthrough Therapy Designation to Alixorexton for Narcolepsy Type 1 - HCPLive
Novel First-in-Class Drug Tied to Improved Cognition in Narcolepsy - Medscape
Real-World Data on the Benefits of Once-Nightly Oxybate in Narcolepsy Management - NeurologyLive
Takeda’s oveporexton shows broader benefits in Phase III narcolepsy studies - The Pharma Letter
Narcolepsy raises your risk of depression, anxiety and social isolation. Why? - Mayo Clinic Press
Eisai Begins Enrolling Phase 2 Study for Narcolepsy Treatment E2086 - Sleep Review
Insights on Comorbidities and Narcolepsy Treatment From World Sleep Congress 2025 - NeurologyLive
Gut Microbiota Imbalance Linked to Narcolepsy, Other Sleep Disorders - Sleep Review
From narcolepsy treatments to symptom management: What to ask your care team - Mayo Clinic Press
Jazz Pharmaceuticals to Present Xywav Narcolepsy Data at 2026 AAN Annual Meeting - Sleep Review
Modafinil and abnormal bleeding in a young lady with narcolepsy: a case report - Frontiers
FDA kicks off review of Takeda's narcolepsy hopeful - pharmaphorum
FDA Approves Pitolisant for Treatment of Cataplexy in Pediatric Narcolepsy - Pharmacy Times – Pharmacy Practice News and Expert Insights
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy - BioWorld News
Hypothalamic functional connectivity, depressive symptoms, and post-treatment SOREMPs in narcolepsy type 1: links to sleep latency and mediation mechanisms - Nature
Orexin agonists among “exciting” emerging therapies for narcolepsy type 1 | AMCP Annual 2026 - Managed Healthcare Executive
Could a drug for narcolepsy change the world? | Zoe Williams - The Guardian
Understanding Narcolepsy as More Than a Sleep Disorder - Psychiatric Times
Alkermes Starts Phase 3 Orexin Trials As Narcolepsy Story Builds - Yahoo Finance
Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1 - NeurologyLive
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1 - Psychiatric Times
Foreign Language Equivalents
Foreign Language Equivalents of 'narcoleptic'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
narcoleptc,   arcoleptic,   narrcoleptic,   narcolepyic,   narcoleptix,   barcoleptic,   narcoleptoc,   narcolpetic,   nsrcoleptic,   narocleptic,   naecoleptic,   narcolrptic,   nnarcoleptic,   narcooleptic,   narcoleotic,   anrcoleptic,   narcoleptci,   naroleptic,   nacroleptic,   narcloeptic,   narcoelptic,   narcokeptic,   narcoleptuc,   nracoleptic,   narcileptic,   nacoleptic,   narccoleptic,   marcoleptic,   narcoleptiic,   narcoleeptic,   narcoleptiv,   naarcoleptic,   narcolepitc,   narcolepttic,   narcolepric,   narcolepptic,   narcolleptic,   narxoleptic,   narcpleptic,   narcolepic,   narcoletpic,   narcolwptic,   nrcoleptic,   narcolepticc,   narcoletic,   natcoleptic,   narcoeptic,   narcole[tic,   narcleptic,   narcolepti,   narvoleptic,   narco;eptic,   narcolptic
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z